Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul 2;12(13):2986-9.
doi: 10.1021/ol101009q.

Synthesis of SL0101 carbasugar analogues: carbasugars via Pd-catalyzed cyclitolization and post-cyclitolization transformations

Affiliations

Synthesis of SL0101 carbasugar analogues: carbasugars via Pd-catalyzed cyclitolization and post-cyclitolization transformations

Mingde Shan et al. Org Lett. .

Abstract

A general approach to the stereoselective synthesis of 5a-carbasugars has been developed. The route mimics our palladium-catalyzed glycosylation/postglycosylation approach to carbohydrates in that it also utilizes a highly regio- and stereospecific palladium-catalyzed allylation and postglycosylation reaction sequence for the installation of either D- or L-cyclitols. This cyclitolization/postcyclitolization sequence was used for the enantioselective synthesis of a cyclitol analogue of SL0101, its D-sugar enantiomer, as well as several acetylation pattern analogues.

PubMed Disclaimer

Figures

Figure 1
Figure 1
RSK2 inhibitors SL0101 and its analogues
Scheme 1
Scheme 1
De Novo Approach to normal sugar and carbasugar
Scheme 2
Scheme 2
Synthesis of two α-Boc-enones from quinic acid
Scheme 3
Scheme 3
Pd-Cyclitolization for α-Boc-enones with BnOH
Scheme 4
Scheme 4
Post-cyclitolization transformation
Scheme 5
Scheme 5
Pd-Cyclitolization for kaempferol with α-l-Boc-enone
Scheme 6
Scheme 6
Synthesis of SL0101 5a-carbasugar α-l-glycoside 4
Scheme 7
Scheme 7
Synthesis of SL0101 5a-carbasugar α-l-glycoside 5 & 6
Scheme 8
Scheme 8
Synthesis of (ent)-6
Scheme 9
Scheme 9
Synthesis of (ent)-5 & (ent)-4

Similar articles

Cited by

References

    1. Nguyen TL. Anticancer Agents Med. Chem. 2008;8:710–716. - PubMed
    1. Smith JA, Poteet-Smith CE, Xu Y, Errington TM, Hecht SM, Lannigan DA. Cancer Res. 2005;65:1027–1034. - PubMed
    1. Maloney DJ, Hecht SM. Org. Lett. 2005;7:1097–1099. - PubMed
    1. Smith JA, Maloney DJ, Clark DE, Xu Y, Hecht SM, Lannigan DA. Bioorg. Med. Chem. 2006;14:6034–6042. - PubMed
    2. Smith JA, Maloney DJ, Hecht SM, Lannigan DA. Bioorg. Med. Chem. 2007;15:5018–5034. - PubMed
    1. Shan M, O'Doherty GA. Org. Lett. 2006;8:5149–5152. - PMC - PubMed

Publication types